Abstract:Min Cai, 1, &ast Yue Deng, 2, &ast Tianyang Hu 3 1 Department of Nephropathy and Rheumatism, Yongchuan Hospital of Chongqing Medical University (The Fifth Clinical College of Chongqing Medical University), Chongqing, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, The Fifth People's Hospital of Chongqing, Chongqing, People's Republic of China; 3 Precision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tianyang Hu, Email Purpose: Acute kidney injury (AKI) is a common complication of acute exacerbation of chronic obstructive pulmonary disease (AECOPD), and inflammation is the potential link between AKI and AECOPD. However, little is known about the incidence and risk stratification of AKI in critically ill AECOPD patients. In this study, we aimed to establish risk model based on white blood cell (WBC)-related indicators to predict AKI in critically ill AECOPD patients. Material and Methods: For the training cohort, data were taken from the Medical Information Mart for eICU Collaborative Research Database (eICU-CRD) database, and for the validation cohort, data were taken from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. The study employed logistic regression analysis to identify the major predictors of WBC-related biomarkers on AKI prediction. Subsequently, a risk model was developed by multivariate logistic regression, utilizing the identified significant indicators. Results: Finally, 3551 patients were enrolled in training cohort, 926 patients were enrolled in validation cohort. AKI occurred in 1206 (33.4%) patients in training cohort and 521 (56.3%) patients in validation cohort. According to the multivariate logistic regression analysis, four WBC-related indicators were finally included in the novel risk model, and the risk model had a relatively good accuracy for AKI in the training set (C-index, 0.764, 95% CI 0.749– 0.780) as well as in the validation set (C-index, 0.738, 95% CI: 0.706– 0.770). Even after accounting for other models, the critically ill AECOPD patients in the high-risk group (risk score > 3.44) still showed an increased risk of AKI (odds ratio: 4.74, 95% CI: 4.07– 5.54) compared to those in low-risk group (risk score ≤ 3.44). Moreover, the risk model showed outstanding calibration capability as well as therapeutic usefulness in both groups for AKI and ICU mortality and in-hospital mortality of critical ill AECOPD patients. Conclusion: The novel risk model showed good AKI prediction performance. This risk model has certain reference value for the risk stratification of AECOPD complicated with AKI in clinically. Keywords: risk model, acute kidney injury, prediction, white blood cell, acute exacerbation of chronic obstructive pulmonary disease A prevalent chronic inflammatory illness of the airways, chronic obstructive pulmonary disease (COPD) is defined by ongoing respiratory symptoms and reduced airflow. 1 COPD is a common disease with high global morbidity and mortality and poses a major health and economic burden in the worldwide, which has become a significant public health issue. COPD was the fifth leading cause of death in 2002 and will rank third by 2030. 2 Acute exacerbations of COPD (AECOPD) are episodes of worsening symptoms and patients who have frequent exacerbations have a lower quality of life, a faster deterioration in lung function, and are at a higher risk of myocardial infarctions, cerebrovascular events, and mortality. 3 Patients may eventually need to be admitted to the intensive care unit (ICU) and undergo invasive mechanical ventilation (IMV) due to acute respiratory failure during an AECOPD. 4 Acute kidney injury (AKI) is a common complication in patients admitted to the ICU. 5 Literature reported 30–60% of critically ill patients developed AKI and AKI is associated with increased morbidity and mortality. 6 Moreover, AKI is recognized as also a severe complication of AECOPD, AECOPD patients with AKI showed higher mortality compared to those without AKI. 7 Hence, it is important to seek risk model or predictors of AKI in critically ill AECOPD patients, especially for biomarkers which can be easily obtained upon admission. AECOPD and AKI share similar pathobiology in the development and progression, such as systemic inflammation. AECOPD is linked to increased systemic and airway inflammation. 8 It is widely acknowledged that inflammation plays a significant role in the development of AKI. 9 Whi -Abstract Truncated-

Correlation Analysis of Early Renal Injury in Elderly Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Serum Cys C Predicts Acute Kidney Injury in Patients with Acute Pancreatitis: A Retrospective Study.

Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis

Elevated serum cystatin C at continuous renal replacement therapy initiation predicts lack of renal recovery.

Elevated Serum Cystatin C at Continuous Renal Replacement Therapy Initiation Predicts Lack of Renal Recovery

Relations Between Markers of Renal Function, Coronary Risk Factors and the Occurrence and Severity of Coronary Artery Disease

In Reply to 'serum Cystatin C May Diagnose Rather Than Predict Acute Kidney Injury'

Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment

Serum Cystatin C As A Potential Biomarker for the Evaluation Copd

Assessment of the Significance of Cysteine Proteinase Inhibitor C and Β2 Microgiobulin in the Diagnosis and Prognosis of Sepsis-Induced Acute Kidney Injury

Prognostic Value of Leukocyte-Based Risk Model for Acute Kidney Injury Prediction in Critically Ill Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

Relationship of Cystatin-C Change and the Prevalence of Death or Dialysis Need after Acute Kidney Injury: a Meta-Analysis.

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

The Association Between Cystatin C and COPD: a Meta-Analysis and Systematic Review

Correlation between serum bilirubin, blood uric acid, and C-reactive protein and the severity of chronic obstructive pulmonary disease

#767 Utility of cystatin C as a predictor for postoperative acute kidney injury in non-cardiac surgeries [S1]

Incidence, Risk Factors, and Prognostic Implications of Acute Kidney Injury in Patients with Acute Exacerbation of COPD